1. Academic Validation
  2. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II

Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II

  • Bioorg Med Chem. 2019 Mar 15;27(6):978-990. doi: 10.1016/j.bmc.2019.01.041.
Jiangying Cao 1 Jie Zang 1 Xiujie Kong 1 Chunlong Zhao 1 Ting Chen 1 Yingying Ran 1 Hang Dong 1 Wenfang Xu 1 Yingjie Zhang 2
Affiliations

Affiliations

  • 1 Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, PR China.
  • 2 Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, PR China. Electronic address: zhangyingjie@sdu.edu.cn.
Abstract

Aminopeptidase N (APN) has been proved to be deeply associated with Cancer angiogenesis, metastasis and invasion. Therefore, APN gains increasing attention as a promising anti-tumor target. In the current study, we report the design, synthesis, biological evaluation and structure-activity relationship of one new series of leucine ureido derivatives containing the 1,2,3-triazole moiety. Among them, compound 31f was identified as the best APN inhibitor with IC50 value being two orders of magnitude lower than that of the positive control bestatin. Compound 31f possessed selective cytotoxicity to several tumor cell lines over the normal cell line human umbilical vein endothelial cells (HUVECs). Notably, when combined with 5-fluorouracil (5-Fu), 31f exhibited synergistic anti-proliferation effect against several tumor cell lines. At the same concentration, 31f exhibited much better anti-angiogenesis activities than bestatin in the HUVECs capillary tube formation assay and the rat thoracic aorta rings test. In the in vitro anti-invasion assay, 31f also exhibited superior potency over bestatin. Moreover, considerable in vivo antitumor potencies of 31f alone or in combination with 5-Fu were observed without significant toxic signs in a mouse heptoma H22 tumor transplant model.

Keywords

Aminopeptidase N; Anti-angiogenesis; Anti-metastasis; CD13; Triazole.

Figures